PCSK9: A Potential Therapeutic Target for Sepsis
Sepsis is a life-threatening organ dysfunction syndrome caused by a dysregulated host response to infection. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is often upregulated in the presence of sepsis and infectious diseases. In sepsis, PCSK9 degraded the low-density lipoprotein cholesterol...
Saved in:
Main Authors: | Yuan Yuan, Wei Wu, Shanshan Sun, Yi Zhang, Zhi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/2687692 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PCSK9-antibodies fail to block PCSK9-induced inflammation in macrophages and cannot recapitulate protective effects of PCSK9-deficiency in experimental myocardial infarction
by: Simon Rauterberg, et al.
Published: (2025-01-01) -
Impact of PCSK9 Immunization on Glycemic Indices in Diabetic Rats
by: Amir Abbas Momtazi-Borojeni, et al.
Published: (2021-01-01) -
PCSK9 affects vascular senescence through the SIRT1 pathway
by: Yuqin Wang, et al.
Published: (2025-03-01) -
PCSK9 Expression in Epicardial Adipose Tissue: Molecular Association with Local Tissue Inflammation
by: Elena Dozio, et al.
Published: (2020-01-01) -
Protective effect of alirocumab, a PCSK9 inhibitor, on the sciatic nerve of rats with diabetic peripheral neuropathy
by: Na Cui, et al.
Published: (2024-03-01)